Creative Planning’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
175,690
+124,893
| +246% | +$155K | ﹤0.01% | 3147 |
|
|
2025
Q1 | $59.9K | Sell |
50,797
-46,019
| -48% | -$54.3K | ﹤0.01% | 3304 |
|
|
2024
Q4 | $177K | Buy |
96,816
+64,407
| +199% | +$118K | ﹤0.01% | 2997 |
|
|
2024
Q3 | $55.1K | Buy |
32,409
+7,629
| +31% | +$13K | ﹤0.01% | 3087 |
|
|
2024
Q2 | $33.9K | Buy |
+24,780
| New | +$33.9K | ﹤0.01% | 2930 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$1.67K | – | 2927 |
|
|
2023
Q3 | $1.67K | Buy |
+200
| New | +$1.67K | ﹤0.01% | 2752 |
|
|
2021
Q2 | – | Sell |
-10,424
| Closed | -$347K | – | 2239 |
|
|
2021
Q1 | $347K | Buy |
+10,424
| New | +$347K | ﹤0.01% | 1670 |
|
|
2017
Q3 | – | Sell |
-6,950
| Closed | -$25K | – | 3068 |
|
|
2017
Q2 | $25K | Sell |
6,950
-11,000
| -61% | -$39.6K | ﹤0.01% | 2996 |
|
|
2017
Q1 | $93K | Buy |
17,950
+3,000
| +20% | +$15.5K | ﹤0.01% | 1998 |
|
|
2016
Q4 | $57K | Buy |
14,950
+1,817
| +14% | +$6.93K | ﹤0.01% | 2277 |
|
|
2016
Q3 | $118K | Buy |
13,133
+3,533
| +37% | +$31.7K | ﹤0.01% | 1722 |
|
|
2016
Q2 | $68K | Sell |
9,600
-1,000
| -9% | -$7.08K | ﹤0.01% | 1924 |
|
|
2016
Q1 | $90K | Sell |
10,600
-300
| -3% | -$2.55K | ﹤0.01% | 1694 |
|
|
2015
Q4 | $143K | Buy |
10,900
+9,600
| +738% | +$126K | ﹤0.01% | 1411 |
|
|
2015
Q3 | $5K | Buy |
+1,300
| New | +$5K | ﹤0.01% | 3574 |
|
|
2015
Q2 | – | Sell |
-1,310
| Closed | -$8K | – | 2310 |
|
|
2015
Q1 | $8K | Sell |
1,310
-200
| -13% | -$1.22K | ﹤0.01% | 3266 |
|
|
2014
Q4 | $12K | Buy |
1,510
+400
| +36% | +$3.18K | ﹤0.01% | 2972 |
|
|
2014
Q3 | $5K | Hold |
1,110
| – | – | ﹤0.01% | 3240 |
|
|
2014
Q2 | $7K | Hold |
1,110
| – | – | ﹤0.01% | 2977 |
|
|
2014
Q1 | $6K | Buy |
1,110
+10
| +0.9% | +$54 | ﹤0.01% | 2939 |
|
|
2013
Q4 | $6K | Buy |
1,100
+1,000
| +1,000% | +$5.46K | ﹤0.01% | 2777 |
|
|
2013
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 3105 |
|
|
2013
Q2 | $0 | Buy |
+100
| New | – | ﹤0.01% | 3103 |
|